Other Clinical Trial - The Effect of Reading Therapy on Newborns

Status Recruiting

Clinical Trial Summary

The primary purpose of this pilot study is to specifically examine the effect of parental reading on the ANS of mother and neonate in the hospital setting. The investigators will examine the effect of live maternal-infant reading on typically developing infants to better understand the physiological benefits of live reading on newborns.

Clinical Trial Description

Supporting infant ANS development has been implicated in their improved cardiorespiratory and neuropsychiatric outcome; furthermore, improved parasympathetic activity, a branch of ANS, is a predictor of the mother-infant relationship, and the best marker for caregiving behavior. In Feldman and Eidelman's 2003 study, they demonstrated that mother-infant skin-to-skin contact, also known as Kangaroo Care, accelerates ANS maturation in pre-term infants, which is critical for their recovery. If reading is shown to have a positive effect on mother infant ANS, hospitals will be able to incorporate this into practice as a feasible alternative for when Kangaroo Care isn't possible. The investigators hope to learn if these reading interventions will help to mitigate distress symptoms, among both mother and baby, within the hospital. The investigators will examine the association of reading therapy with the infant's crying patterns, length of stay in the hospital, weight gain, and behavior compared to before the reading was done. Seeing that Scala's findings from 2018 is the only indication of physiologic benefits of reading to infants in the hospital, additional research is required in this particular area. The testing and application of reading therapy in the Neonatal Intensive Care Unit (NICU) would improve a high-stress environment for both parents and infants. Data collected from this project will not only add some much-needed information to the limited knowledge of the physiological effects of reading on neonates, but also demonstrate how infant outcomes can be improved in a cost-effective, efficient manner within the hospital setting. ;

Study Design

Related Conditions & MeSH terms

Autonomic Nervous System Diseases
Nervous System Diseases
Primary Dysautonomias

Clinical Trial Details

NCT number	NCT05004857
Study type	Interventional
Source	Tulane University
Contact	Meghan Howell, MD, MS
Phone	504-428-9201
Email	mhowell2@tulane.edu
Status	Recruiting
Phase	N/A
Start date	September 17, 2021
Completion date	March 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00547911` - Augmenting Effects of L-DOPS With Carbidopa and Entacapone	Phase 1/Phase 2
Completed	`NCT03327493` - Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMO	N/A
Recruiting	`NCT05239065` - Personalized Stress Management With Application of Portable Devices in Occupational Populations	N/A
Completed	`NCT03064256` - Aerobic Physical Training and Heart Rate Variability in Hypertersion	N/A
Completed	`NCT02594488` - Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction	N/A
Completed	`NCT00775853` - Biomarkers of Risk of Parkinson Disease
Recruiting	`NCT03426085` - The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes	Phase 2
Completed	`NCT03322904` - Sympathetic-parasympathetic Ratio of Our Gaze	N/A
Terminated	`NCT02963181` - Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension	Early Phase 1
Not yet recruiting	`NCT02365974` - Transcutaneous Electrical Nerve Stimulation (TENS) on Arterial Stiffness and Blood Pressure	N/A
Completed	`NCT00001418` - PET Scan in Patients With Neurocardiologic Disorders	N/A
Not yet recruiting	`NCT06236945` - HUTT to Assess Cardiac Autonomic Nervous Function
Completed	`NCT02397681` - Autonomic Responses During the Valsalva Maneuver and Deep Breathing Test Depend on the Experimental Setup	N/A
Completed	`NCT02584712` - Effect of Exercise Training in Autonomic Modulation in Breast Cancer Patients	N/A
Recruiting	`NCT00422474` - Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic Stroke	N/A
Terminated	`NCT00581477` - Treatment of Orthostatic Hypotension	Phase 2/Phase 3
Enrolling by invitation	`NCT02725060` - Autoimmune Basis for Postural Tachycardia Syndrome	N/A
Completed	`NCT00748059` - The Pathophysiology of Orthostatic Hypotension	Phase 1
Completed	`NCT02830022` - Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children (APAUTRES)	N/A
Enrolling by invitation	`NCT04100486` - Non-Invasive Bioelectronic Analytics

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.